Prostate Cancer Diagnosis: AUA Guidelines on use of PSA Biomarkers, MRI and Biopsy Techniques Webcast (2024) |
|
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Non-Physician Participation
|
|
$0.00 |
Prostate cancer detection remains one of the most common and most controversial aspects of urological practice. In addition to the complexities around screening and use of PSA, the role of other biomarkers, biopsy techniques such as transperineal biopsy and MRI for targeted biopsy are evolving rapidly. This course is intended for urologists, advanced practice providers and trainees interested in using the most evidence-based methods for optimizing detection of clinically important prostate cancers, while improving patient experience and minimizing complications. |
Prostate Cancer Update (2024): Expert Guidance for APPs Webcast |
|
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Non-Physician Participation
|
|
$0.00 |
|
Prostate Cancer Update (2024): Expert Guidance for Urologists Webcast |
|
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Non-Physician Participation
|
|
$0.00 |
|
Self-Assessment Study Program SASP (2023) |
|
|
|
$350.00 |
|
Self-Assessment Study Program SASP (2024) |
|
|
|
$720.00 |
|
Self-Assessment Study Program SASP (2025) |
|
|
|
$755.00 |
|
Self-Assessment Study Program SASP (2025) 5-Year Bundle Online + App - Single User |
|
|
|
$755.00 |
|
Self-Assessment Study Program SASP (2025) Online + App - Single User |
|
|
|
$360.00 |
|
Sequencing of Agents Podcast (2024) |
|
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Non-Physician Participation
|
|
$0.00 |
Based on the documented need for additional education in prostate cancer, the AUA has developed AUA Expert Exchange Podcast: Discussions in Prostate Cancer. To address the educational needs of the urologic care team, this episode will focus on:Sequencing of Agents |
The Changing Face of Advanced Prostate Cancer 2023 Webcast (2024) |
|
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Non-Physician Participation
|
|
$0.00 |
This is an ongoing course on advanced prostate cancer at the annual AUA since 2012, and the changes over the last decade have been nothing less than breathtaking! In the early years, it was all about metastatic castrate-resistant prostate cancer (CRPC) with multiple new therapeutic advances starting in 2010 followed by novel oral hormonal therapies and a focus on bone-targeted agents. Later, the course expanded to cover hormone-sensitive (HS) advanced disease due to the new data on chemotherapy and novel ADT extending survival in new M1 patients. |
The Evolving Landscape of Advanced Prostate Cancer Treatment: A Guidelines and Case-Based Discussion Webcast (2024) |
|
- 4.75 AMA PRA Category 1 Credit™
- 4.75 Non-Physician Participation
|
|
$0.00 |
This comprehensive, interactive course equips urologic professionals with the knowledge and skills needed to effectively manage patients with advanced prostate cancer. Through an in-depth exploration of guidelines, treatment modalities, and emerging therapies, participants will gain a thorough understanding of this complex disease and its evolving landscape. |
The Journal of Urology® Volumes 209/210 Home Study Course (2023) |
|
|
|
$80.00 |
THE MOST COMPREHENSIVE AND AFFORDABLE SELF-STUDY CME PRODUCT!Make the most of your Journal of Urology® Subscription! |
The Journal of Urology® Volumes 211/212 Home Study Course (2024) |
|
|
|
$80.00 |
THE MOST COMPREHENSIVE AND AFFORDABLE SELF-STUDY CME PRODUCT!Make the most of your Journal of Urology® Subscription! |
The Journal of Urology® Volumes 213/214 Home Study (2025) |
|
|
|
$0.00 |
EXCLUSIVELY AVAILABLE TO AUA MEMBERS!Make the most of your Journal of Urology® Subscription! |
The Surgical Management of BPH and Updates from the AUA Clinical Guidelines Podcast (2024) |
|
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Non-Physician Participation
|
|
$0.00 |
As a direct result of the evolving technologies and procedures related to the surgical management of BPH, urologists must continue increasing their knowledge and skills of the various treatment options available. |